The Journal of Immunology, Vol 138, Issue 4 1143-1149, Copyright © 1987 by American Association of Immunologists

ARTICLES

Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba

A Ueda, JF Kearney, KH Roux and JE Volanakis

We used four mouse monoclonal antibodies (Mab) as probes of functional sites of human complement protein B. Two Mab, HA4-1B (gamma 2a kappa) and HA4-15 (gamma 2a kappa), reacted with the same or adjacent epitopes on the Bb fragment of B, while the other two, HA4-1A (gamma 1 kappa) and FD3-20 (gamma 1 kappa), reacted with distinct epitopes on Ba. All reactive epitopes were expressed on native B and only one, recognized by the anti-Ba Mab HA4-1A was more reactive on isolated Ba than on B. These binding specificities were determined by direct binding radioassays and confirmed by inhibition studies. Immunoelectron microscopy of B and Bb in complex with anti-Ba and anti-Bb revealed that the recognized epitopes are on opposite sides of the molecule and are on discrete domains. All four Mab inhibited the hemolytic activity of B, although with different efficiencies and through different mechanisms. The main effect of the two anti-Bb Mab was an increased rate of loss of hemolytic sites from preformed EC3bBb C3 convertase presumably through accelerated dissociation of Bb. On the other hand, the main effect of the two anti-Ba Mab was inhibition of binding of B to C3b. HA4-1A was more efficient, inhibiting by 50% the binding of [125I]B to EC3b at 10 micrograms/ml as IgG and at 13 micrograms/ml as Fab. The data suggest that a binding site for C3b on intact B is located on the Ba portion of the molecule.

This article has been cited by other articles:

				P. Lukacik, P. Roversi, J. White, D. Esser, G. P. Smith, J. Billington, P. A. Williams, P. M. Rudd, M. R. Wormald, D. J. Harvey, et al. Complement regulation at the molecular level: The structure of decay-accelerating factor PNAS, February 3, 2004; 101(5): 1279 - 1284. [Abstract] [Full Text] [PDF]

				J. M. Inal and J. A. Schifferli Complement C2 Receptor Inhibitor Trispanning and the {beta}-Chain of C4 Share a Binding Site for Complement C2 J. Immunol., May 15, 2002; 168(10): 5213 - 5221. [Abstract] [Full Text] [PDF]

				Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis Complement activation in factor D-deficient mice PNAS, November 20, 2001; (2001) 261428398. [Abstract] [Full Text] [PDF]

				Q. Pan, R. O. Ebanks, and D. E. Isenman Two Clusters of Acidic Amino Acids Near the NH2 Terminus of Complement Component C4 {alpha}'-Chain Are Important for C2 Binding J. Immunol., September 1, 2000; 165(5): 2518 - 2527. [Abstract] [Full Text] [PDF]

				Y. Xu, A. Circolo, H. Jing, Y. Wang, S. V. L. Narayana, and J. E. Volanakis Mutational Analysis of the Primary Substrate Specificity Pocket of Complement Factor B. ASP226 IS A MAJOR STRUCTURAL DETERMINANT FOR P1-ARG BINDING J. Biol. Chem., January 7, 2000; 275(1): 378 - 385. [Abstract] [Full Text] [PDF]

				A. J. Szalai, S. B. Digerness, A. Agrawal, J. F. Kearney, R. P. Bucy, S. Niwas, J. M. Kilpatrick, Y. S. Babu, and J. E. Volanakis The Arthus Reaction in Rodents: Species-Specific Requirement of Complement J. Immunol., January 1, 2000; 164(1): 463 - 468. [Abstract] [Full Text] [PDF]

				D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby Mutations of the Type A Domain of Complement Factor B That Promote High-Affinity C3b-Binding J. Immunol., March 1, 1999; 162(5): 2906 - 2911. [Abstract] [Full Text] [PDF]

				D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby A Conserved Element in the Serine Protease Domain of Complement Factor B J. Biol. Chem., October 2, 1998; 273(40): 25996 - 26000. [Abstract] [Full Text] [PDF]

				Z.-B. Zhu, T. P. Atkinson, and J. E. Volanakis A Novel Type II Complement C2 Deficiency Allele in an African-American Family J. Immunol., July 15, 1998; 161(2): 578 - 584. [Abstract] [Full Text] [PDF]

				S. Kim, S. V. L. Narayana, and J. E. Volanakis Crystal Structure of a Complement Factor D Mutant Expressing Enhanced Catalytic Activity J. Biol. Chem., October 13, 1995; 270(41): 24399 - 24405. [Abstract] [Full Text] [PDF]

				D. E. Hourcade, L. M. Wagner, and T. J. Oglesby Analysis of the Short Consensus Repeats of Human Complement Factor B by Site-directed Mutagenesis J. Biol. Chem., August 25, 1995; 270(34): 19716 - 19722. [Abstract] [Full Text] [PDF]

				Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis Complement activation in factor D-deficient mice PNAS, December 4, 2001; 98(25): 14577 - 14582. [Abstract] [Full Text] [PDF]